Specific Pharma A/s Sustainability Profile
Specific Pharma A/S, headquartered in Denmark (DK), is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of innovative drug delivery systems. Founded in [year], the company has established a strong presence in major operational regions across Europe and beyond, focusing on enhancing patient outcomes through advanced pharmaceutical solutions. With a commitment to quality and innovation, Specific Pharma A/S offers a range of unique products and services, including tailored formulations and cutting-edge delivery technologies. The company has achieved notable milestones, positioning itself as a trusted partner in the healthcare sector. Recognised for its expertise and dedication, Specific Pharma A/S continues to lead the way in providing effective and reliable pharmaceutical solutions, making significant contributions to the industry.
DitchCarbon Score
How does Specific Pharma A/s's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Specific Pharma A/s's score of 64 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Specific Pharma A/s, headquartered in Denmark (DK), currently does not report any direct carbon emissions data, as indicated by the absence of specific figures in kg CO2e. The company is a current subsidiary of PHOENIX Pharmahandel GmbH & Co KG, which may influence its climate commitments and emissions reporting. While Specific Pharma A/s has not established specific reduction targets or initiatives, it is important to note that emissions data and climate strategies may be inherited from its parent company, PHOENIX Pharmahandel SE. This cascading relationship suggests that any climate commitments or performance metrics may align with the broader sustainability goals of the parent organisation. As of now, Specific Pharma A/s has not publicly committed to any specific climate pledges or initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). The lack of reported emissions data and reduction targets indicates a potential area for development in their environmental strategy. In summary, Specific Pharma A/s is currently in a position where it inherits climate-related data and commitments from its parent company, but it has yet to establish its own specific emissions reporting or reduction initiatives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 20,501,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 47,693,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 140,907,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - | - | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
How Carbon Intensive is Specific Pharma A/s's Industry?
How Carbon Intensive is Specific Pharma A/s's Location?
Specific Pharma A/s's Scope 3 Categories Breakdown
Specific Pharma A/s's Scope 3 emissions, which decreased by 3% last year and increased significantly since 2015, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" representing nearly all of their reported Scope 3 footprint.
Top Scope 3 Categories
Specific Pharma A/s's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Specific Pharma A/s has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
